NCT00704574View on ClinicalTrials.gov

Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes

CompletedOBSERVATIONAL

Enrollment

159

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

No extra intervention, only normal clinical practise for treatment of type 1 diabetes

Trial Locations (1)

221 85

Novo Nordisk Investigational Site, Lund

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY